1. Home
  2. PATK vs CGON Comparison

PATK vs CGON Comparison

Compare PATK & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PATK
  • CGON
  • Stock Information
  • Founded
  • PATK 1959
  • CGON 2010
  • Country
  • PATK United States
  • CGON United States
  • Employees
  • PATK N/A
  • CGON N/A
  • Industry
  • PATK Auto Parts:O.E.M.
  • CGON
  • Sector
  • PATK Consumer Discretionary
  • CGON
  • Exchange
  • PATK Nasdaq
  • CGON NYSE
  • Market Cap
  • PATK 2.9B
  • CGON 2.3B
  • IPO Year
  • PATK N/A
  • CGON 2024
  • Fundamental
  • Price
  • PATK $125.14
  • CGON $38.05
  • Analyst Decision
  • PATK Strong Buy
  • CGON Strong Buy
  • Analyst Count
  • PATK 7
  • CGON 6
  • Target Price
  • PATK $133.29
  • CGON $64.17
  • AVG Volume (30 Days)
  • PATK 126.3K
  • CGON 476.7K
  • Earning Date
  • PATK 10-24-2024
  • CGON 11-02-2024
  • Dividend Yield
  • PATK 1.76%
  • CGON N/A
  • EPS Growth
  • PATK N/A
  • CGON N/A
  • EPS
  • PATK 6.97
  • CGON N/A
  • Revenue
  • PATK $3,597,376,000.00
  • CGON $539,000.00
  • Revenue This Year
  • PATK $10.47
  • CGON $478.43
  • Revenue Next Year
  • PATK $8.43
  • CGON $415.25
  • P/E Ratio
  • PATK $17.96
  • CGON N/A
  • Revenue Growth
  • PATK N/A
  • CGON N/A
  • 52 Week Low
  • PATK $70.15
  • CGON $25.77
  • 52 Week High
  • PATK $136.00
  • CGON $50.23
  • Technical
  • Relative Strength Index (RSI)
  • PATK 49.62
  • CGON N/A
  • Support Level
  • PATK $124.42
  • CGON N/A
  • Resistance Level
  • PATK $129.76
  • CGON N/A
  • Average True Range (ATR)
  • PATK 3.42
  • CGON 0.00
  • MACD
  • PATK -0.81
  • CGON 0.00
  • Stochastic Oscillator
  • PATK 25.38
  • CGON 0.00

About PATK Patrick Industries Inc.

Patrick Industries Inc makes and sells building products and materials for recreational vehicles and manufactured housing. The company is organized into two segments based on product type: manufacturing and distribution. The manufacturing segment, which generates the majority of revenue, sells laminated and vinyl products that include furniture, shelving, cabinets, bath fixtures, and countertops. The distribution segment sells prefinished wall and ceiling panels, as well as electrical and plumbing products for the RV and manufactured housing industries. One of the firm's RV customers makes up a portion of revenue.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: